SEC Form 4 · accession 0001628280-26-040583
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Violin
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 3, 2026 · 7:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001253689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $17.01 | Jun 2, 2026 | A | 11,050 | A | — | Jun 2, 2036 | Ordinary Shares | 11,050 | 11,050 | D |
Explanation of responses
- F1This option represents a right to purchase 11,050 of the Issuer's ordinary shares and vests in full on the earlier of (i) June 2, 2027 or (ii) the date of the Issuer's next annual meeting of shareholders, in each case, subject to the Reporting Person's continued service to the Issuer.